- Home
- ICUCW vs PRPO Comparison
ICUCW vs PRPO Comparison
Compare ICUCW & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUCW
- PRPO
- Stock Information
- Founded
- ICUCW N/A
- PRPO N/A
- Country
- ICUCW United States
- PRPO United States
- Employees
- ICUCW 19
- PRPO N/A
- Industry
- ICUCW Biotechnology: Pharmaceutical Preparations
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- ICUCW Health Care
- PRPO Industrials
- Exchange
- ICUCW Nasdaq
- PRPO Nasdaq
- Market Cap
- ICUCW N/A
- PRPO N/A
- IPO Year
- ICUCW 2021
- PRPO N/A
- Fundamental
- Price
- ICUCW $0.03
- PRPO $11.46
- Analyst Decision
- ICUCW
- PRPO
- Analyst Count
- ICUCW 0
- PRPO 0
- Target Price
- ICUCW N/A
- PRPO N/A
- AVG Volume (30 Days)
- ICUCW N/A
- PRPO 10.5K
- Earning Date
- ICUCW N/A
- PRPO 05-14-2025
- Dividend Yield
- ICUCW N/A
- PRPO N/A
- EPS Growth
- ICUCW N/A
- PRPO N/A
- EPS
- ICUCW N/A
- PRPO N/A
- Revenue
- ICUCW N/A
- PRPO $20,029,000.00
- Revenue This Year
- ICUCW N/A
- PRPO N/A
- Revenue Next Year
- ICUCW N/A
- PRPO N/A
- P/E Ratio
- ICUCW N/A
- PRPO N/A
- Revenue Growth
- ICUCW N/A
- PRPO 26.67
- 52 Week Low
- ICUCW N/A
- PRPO $3.90
- 52 Week High
- ICUCW N/A
- PRPO $11.76
- Technical
- Relative Strength Index (RSI)
- ICUCW N/A
- PRPO 73.69
- Support Level
- ICUCW N/A
- PRPO $10.26
- Resistance Level
- ICUCW N/A
- PRPO $11.58
- Average True Range (ATR)
- ICUCW 0.00
- PRPO 0.91
- MACD
- ICUCW 0.00
- PRPO 0.17
- Stochastic Oscillator
- ICUCW 0.00
- PRPO 98.03
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.